28 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 28 of 28 clinical reviews.
Modafinil induces CYP3A4, an enzyme that contributes to apixaban clearance. This raises a plausible but not formally studied risk of reduced apixaban exposure. Here is what the FDA labels establish, what pharmacology suggests, and what remains unverified.
Modafinil induces CYP3A4, which can lower atorvastatin blood levels and reduce statin efficacy. Learn the mechanism, clinical significance, monitoring plan, and alternative statin options.
Modafinil (Provigil) may reduce hormonal contraceptive efficacy through CYP3A4 induction. What the FDA label says, what pharmacokinetic data show, and how to counsel patients on backup contraception.
Clinical guide to the modafinil-bupropion drug interaction covering CYP enzyme effects, seizure threshold concerns, dose adjustments, and physician monitoring protocols.
A clinical review of the pharmacokinetic relationship between modafinil (Provigil) and finasteride, covering CYP3A4 induction, the limits of current evidence, and practical monitoring steps.
Is it safe to take Provigil (modafinil) with metformin? A guide covering CYP enzyme interactions, blood glucose effects, monitoring protocols, and dose-adjustment considerations.
Can you take Provigil with ibuprofen or naproxen? A breakdown of the modafinil-NSAID interaction, covering CYP metabolism, GI risk, renal concerns, and dose-adjustment guidance.
A guide to the modafinil-prednisone drug interaction, covering CYP3A4 induction, reduced steroid exposure, glucose effects, and clinical monitoring.
Board-reviewed guide to the modafinil-pregabalin drug interaction covering CYP pharmacokinetics, pharmacodynamic CNS effects, monitoring, dose adjustment, and patient counseling.
Modafinil induces CYP3A4 and can lower simvastatin blood levels by up to 50%. Learn the mechanism, severity rating, dose adjustments, and monitoring steps from FDA labels and primary literature.
Clinical review of modafinil interactions with SSRIs including sertraline and escitalopram. Covers CYP2C19 inhibition, serotonin syndrome risk, dose adjustment, and monitoring protocols.
What is actually known and unknown about combining modafinil (Provigil) with acetaminophen (Tylenol): the enzyme mechanism, FDA labeling, hepatic risk factors, and what a prescriber or pharmacist should verify before chronic co-use.
A guide to the modafinil, benzodiazepine drug interaction: mechanisms, severity, monitoring parameters, dose adjustments, and patient counseling points backed by primary literature.
Modafinil (Provigil) inhibits CYP2C19, the enzyme that activates clopidogrel. Learn the clinical significance, monitoring strategy, and safer alternatives from HealthRX.com's medical team.
A clinical deep-dive into the modafinil, diphenhydramine drug interaction, covering CYP enzyme effects, pharmacodynamic opposition, severity ratings, dose adjustments, and patient counseling.
A guide to the modafinil, gabapentin drug interaction: mechanisms, sedation risk, CNS depression overlap, CYP induction, renal considerations, monitoring parameters, and safe co-prescribing guidance.
A clinical review of the modafinil-levothyroxine drug interaction covering CYP3A4 induction, absorption timing, TSH monitoring, and dose-adjustment protocols.
A clinician-level guide to the modafinil, opioid drug interaction covering CYP3A4 induction, pharmacodynamic CNS effects, tramadol-specific seizure risk, dose-adjustment, and monitoring for oxycodone, hydrocodone, and tramadol.
A clinician-oriented review of the modafinil and PPI (omeprazole, pantoprazole) drug interaction: mechanism, evidence quality, monitoring, and what still needs verification.
Modafinil (Provigil) induces CYP3A4, which metabolizes progesterone. Learn how this interaction reduces hormone levels, what clinical monitoring looks like, and how prescribers manage the combination safely.
Modafinil (Provigil) induces CYP3A4, the enzyme partly responsible for clearing rivaroxaban. This page separates what is established, what is pharmacologically plausible, and what remains unverified, with a checklist for clinicians and pharmacists.
Modafinil (Provigil) and sildenafil share CYP3A4 metabolism. Learn the pharmacokinetic interaction, clinical severity, dose adjustments, and monitoring recommendations backed by FDA labeling and primary literature.
A guide to the modafinil, SNRI drug interaction, covering serotonin syndrome risk, CYP enzyme effects, blood pressure monitoring, and safe co-prescribing strategies for venlafaxine and duloxetine.
How modafinil (Provigil) and tadalafil (Cialis, Adcirca) may interact through the CYP3A4 enzyme pathway, what is established from FDA labeling versus what remains unstudied, and what to verify with a prescriber or pharmacist.
A guide to the modafinil and testosterone drug interaction, covering CYP3A4 induction, androgen pharmacokinetics, polycythemia risk, lipid effects, and clinical monitoring protocols.
A guide to the modafinil, trazodone drug interaction, covering CYP enzyme mechanisms, sedation overlap, severity ratings, dose-adjustment strategies, and monitoring protocols.
Modafinil (Provigil) inhibits CYP2C9 and may raise warfarin plasma levels, increasing bleeding risk. Learn the mechanism, severity, monitoring plan, and dose-adjustment guidance.
A guide to the modafinil, zolpidem drug interaction: mechanism, severity, monitoring, dose adjustment, and patient counseling.